BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34983824)

  • 1. Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth.
    Zapletal E; Vasiljevic T; Busson P; Matijevic Glavan T
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis.
    Katakam S; Anand S; Martin P; Riggi N; Stamenkovic I
    Life Sci Alliance; 2022 Mar; 5(3):. PubMed ID: 34983824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damage-associated molecular patterns in cancer: a double-edged sword.
    Hernandez C; Huebener P; Schwabe RF
    Oncogene; 2016 Nov; 35(46):5931-5941. PubMed ID: 27086930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
    Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.
    Francica BJ; Ghasemzadeh A; Desbien AL; Theodros D; Sivick KE; Reiner GL; Hix Glickman L; Marciscano AE; Sharabi AB; Leong ML; McWhirter SM; Dubensky TW; Pardoll DM; Drake CG
    Cancer Immunol Res; 2018 Apr; 6(4):422-433. PubMed ID: 29472271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING: a master regulator in the cancer-immunity cycle.
    Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
    Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Akhmetova K; Balasov M; Chesnokov I
    Elife; 2021 Sep; 10():. PubMed ID: 34467853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Set Knowledge Discovery with Enrichr.
    Xie Z; Bailey A; Kuleshov MV; Clarke DJB; Evangelista JE; Jenkins SL; Lachmann A; Wojciechowicz ML; Kropiwnicki E; Jagodnik KM; Jeon M; Ma'ayan A
    Curr Protoc; 2021 Mar; 1(3):e90. PubMed ID: 33780170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ewing's Sarcoma.
    Riggi N; Suvà ML; Stamenkovic I
    N Engl J Med; 2021 Jan; 384(2):154-164. PubMed ID: 33497548
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities.
    Huang B; Song BL; Xu C
    Nat Metab; 2020 Feb; 2(2):132-141. PubMed ID: 32694690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Organoids: Tools for Understanding Biology and Treating Diseases.
    Schutgens F; Clevers H
    Annu Rev Pathol; 2020 Jan; 15():211-234. PubMed ID: 31550983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and Cancer: Triggers, Mechanisms, and Consequences.
    Greten FR; Grivennikov SI
    Immunity; 2019 Jul; 51(1):27-41. PubMed ID: 31315034
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.